Pharmaceutical compositions for intranasal administration of calcitonin
US5183802A · kind A · utility
11Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 1988 |
| Grant date | Feb 2, 1993 |
| Priority date | — |
| Expiry date | Nov 14, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for the treatment of osteoporosis and related diseases comprise calcitonin and, as an absorption enhancer, a glycyrrhizinate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.